BioSpace News Archive

Policy

Biogen Secures Tecfidera Exclusivity in EU Until Early 2025

The European Commission upheld exclusive marketing protection in Europe for Biogen’s multiple sclerosis therapy Tecfidera until February 3, 2025, staving off generic competition.

December 20, 2023
·
2 min read
·
Tristan Manalac
Policy

German Court Nullifies CureVac’s Patent Case Against BioNTech

A court in Germany on Tuesday nullified one of CureVac’s intellectual property rights in a patent case against BioNTech. However, court proceedings involving seven other patent rights will continue.

December 20, 2023
·
2 min read
·
Tyler Patchen
Drug Development

UniQure Touts Phase I/II Results for Huntington’s Disease Candidate, Wall Street Balks

Gene therapy company uniQure announced Tuesday “ongoing evidence” of a clinical benefit for its Huntington’s disease treatment. However, investors were not impressed as the stock dropped nearly 20%.

December 20, 2023
·
2 min read
·
Tyler Patchen
Lone Star Bio

Colossal Announces the Tasmania Thylacine Advisory Committee

Colossal Biosciences, the breakthrough genetic engineering and de-extinction company, is pleased to announce the formation of the Tasmania Thylacine Advisory Committee.

December 20, 2023
·
4 min read
Business

858 Therapeutics Expands Leadership Team to Support Transition to the Clinic

858 Therapeutics is pleased to announce today that it has named Katherine Bell-McGuinn, M.D., Ph.D., as Chief Medical Officer.

December 20, 2023
·
2 min read
Dxcover To Present at BIOTECH SHOWCASE™ 2024

Dxcover Limited today announced that Founder and newly announced CEO Matthew Baker, PhD, will be presenting at Biotech Showcase 2024.

December 20, 2023
·
2 min read
Genetown

Thermo Fisher Scientific Announces Launch of Innovative CorEvitas Pharmacovigilance Platform for Clinical Research Registries

Thermo Fisher Scientific Inc. today announced the launch of CorEvidence, a proprietary cloud-based data lake platform optimizing pharmacovigilance case processing and safety data management processes.

December 20, 2023
·
2 min read
Business

Multiply Labs and Akron Bio Partner to Automate the Use of cGMP-Compliant Liquid Cytokines in Cell Therapy Manufacturing

Multiply Labs and Akron Bio (“Akron”), a leading supplier of critical materials and services for advanced therapies, today announced a non-exclusive partnership focused on automating and standardizing the use of cytokines in cell therapy manufacturing.

December 20, 2023
·
3 min read
FABHALTA (iptacopan) Now Available from Onco360 as the First FDA-Approved Oral Monotherapy Approved for the Treatment of Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Novartis for Fabhalta® (iptacopan) as the first oral monotherapy approved for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH).

December 20, 2023
·
3 min read
Deals

Hudson Robotics and Art Robbins Instruments Strengthens Portfolio with Acquisition of Tomtec Inc.

Hudson Robotics and Art Robbins Instruments (“Hudson” or “HR”), a global laboratory automation solutions provider, and Argosy Healthcare Partners portfolio company, has acquired Tomtec Inc. (“Tomtec”).

December 20, 2023
·
3 min read